Scarica l'app Stockscreener
15.55
6.21%
-1.03
Dopo l'orario di chiusura:
15.55
Oruka Therapeutics Inc Borsa (ORKA) Ultime notizie
Short Squeeze: Will Generation Income Properties Inc. Equity Warrant announce a stock splitWeekly Trade Recap & AI Optimized Trading Strategy Guides - khodrobank.com
Options Flow: Will Oruka Therapeutics Inc outperform tech stocksJuly 2025 Decliners & Expert Verified Movement Alerts - khodrobank.com
Should you wait for a breakout in Oruka Therapeutics Inc.Exit Point & Daily Stock Trend Reports - newser.com
Will Oruka Therapeutics Inc. bounce back from current supportTrade Signal Summary & Free Accurate Trade Setup Notifications - newser.com
Oruka Therapeutics (NASDAQ:ORKA) Upgraded at Wall Street Zen - MarketBeat
Visual analytics tools that track Oruka Therapeutics Inc. performanceJuly 2025 Sentiment & Accurate Buy Signal Notifications - newser.com
Is Oruka Therapeutics Inc. forming a bottoming base2025 EndofYear Setup & Free Expert Verified Stock Movement Alerts - newser.com
Analyzing Oruka Therapeutics Inc. with multi timeframe chartsTrade Entry Report & Consistent Profit Alerts - newser.com
Jobs Data: Can Oruka Therapeutics Inc deliver consistent EPS growthWeekly Market Summary & Daily Technical Stock Forecast Reports - khodrobank.com
Oruka Therapeutics (NASDAQ:ORKA) Stock Price Expected to Rise, BTIG Research Analyst Says - MarketBeat
Is Oruka Therapeutics Inc. stock bottoming outPortfolio Profit Report & Stock Market Timing Techniques - newser.com
Will Oruka Therapeutics Inc. continue its uptrend2025 Key Highlights & Consistent Return Investment Signals - newser.com
Short Covering: How does Oruka Therapeutics Inc compare to its peersTrade Analysis Summary & Accurate Entry/Exit Alerts - khodrobank.com
Candlestick signals on Oruka Therapeutics Inc. stock today2025 Dividend Review & Short-Term High Return Ideas - newser.com
Oruka Therapeutics (NASDAQ:ORKA) Shares Gap UpStill a Buy? - MarketBeat
IPO Launch: Is now the right time to enter NWBITrade Risk Assessment & Capital Protection Trading Alerts - خودرو بانک
Quantitative breakdown of Oruka Therapeutics Inc. recent moveWeekly Stock Recap & Weekly Return Optimization Alerts - newser.com
Volume Recap: Is Oruka Therapeutics Inc.’s growth already priced inTrade Analysis Report & Risk Adjusted Swing Trade Ideas - khodrobank.com
Aug Weekly: Will Oruka Therapeutics Inc benefit from AI trendsQuarterly Market Review & High Win Rate Trade Alerts - khodrobank.com
Oruka Therapeutics stock price target raised to $56 at BTIG on promising drug data - Investing.com Canada
Volatility clustering patterns for Oruka Therapeutics Inc.Market Trend Report & Consistent Income Trade Ideas - newser.com
Oruka Therapeutics, Regeneron, natgas companies - TradingView
Oruka reveals $180M financing and late breaking psoriasis data - The Pharma Letter
Lyft, Oruka Therapeutics, Roivant Sciences, Workday And Other Big Stocks Moving Higher On Wednesday - Benzinga
Oruka Therapeutics jumps after positive early-stage study data for psoriasis drug - TradingView
Oruka Therapeutics, Up 9%, Is Trying To Take On AbbVie's Biggest Moneymaker - inkl
Oruka jumps as lead drug outperforms AbbVie’s Skyrizi in early-stage trial - Seeking Alpha
Oruka Therapeutics stock surges after positive Phase 1 results By Investing.com - Investing.com Canada
Oruka Therapeutics raises $180 million in private placement By Investing.com - Investing.com Canada
Oruka Therapeutics Says ORKA-001 Interim Early-Stage Data Supports Extended Dosing Intervals; Plans $180 Million Private Placement - MarketScreener
Oruka’s IL-23 antibody shows potential for once-yearly psoriasis dosing - Investing.com Nigeria
Oruka Therapeutics (NASDAQ:ORKA) Stock Price Down 5.4%Should You Sell? - MarketBeat
Oruka Therapeutics, Inc. announced that it expects to receive $179.999998 million in funding from a group of investors - MarketScreener
Oruka Therapeutics raises $180 million in private placement - Investing.com
Relative strength of Oruka Therapeutics Inc. in sector analysis2025 Performance Recap & AI Powered Buy and Sell Recommendations - newser.com
Oruka Therapeutics Reports Positive Interim Data From Phase 1 Study Of ORKA-001 - Nasdaq
Oruka Therapeutics Announces $180 Million Private Placement - GlobeNewswire
Oruka Therapeutics announces positive interim phase 1 results for ORKA-001 - MarketScreener
$180 Million Financing: Biotech Oruka Therapeutics Attracts Elite Healthcare Investors for Skin Disease Programs - Stock Titan
Oruka Therapeutics Announces Positive Interim Phase 1 Results for ORKA-001 - GlobeNewswire
100-Day Half-Life, 3x Longer Than Current Drugs: Oruka's ORKA-001 Could Enable Once-Yearly Psoriasis Treatment - Stock Titan
Gainers Report: How does Oruka Therapeutics Inc compare to its peersMarket Activity Summary & Free Expert Verified Stock Movement Alerts - خودرو بانک
Published on: 2025-09-16 19:43:47 - khodrobank.com
Stock Recap: What’s the profit margin of BZUNEarnings Summary Report & Weekly Sector Rotation Insights - خودرو بانک
Is Oruka Therapeutics Inc. stock poised for growthRisk Management & Free Technical Confirmation Trade Alerts - newser.com
Aug Update: Is Contineum Therapeutics Inc. a defensive stockJuly 2025 Reactions & Weekly Watchlist for Hot Stocks - khodrobank.com
Sentiment Recap: Can Oruka Therapeutics Inc. expand into new marketsEarnings Overview Summary & AI Powered Trade Plan Recommendations - khodrobank.com
Sentiment Watch: Will Oruka Therapeutics Inc stock hit new highs in YEARWeekly Profit Recap & Low Volatility Stock Recommendations - خودرو بانک
Aug Decliners: What is Oruka Therapeutics Incs book value per shareDividend Hike & Low Drawdown Investment Ideas - khodrobank.com
Portfolio Recap: Is Lion Group Holding Ltd Equity Warrant forming a breakout pattern2025 Market WrapUp & Reliable Price Action Trade Plans - خودرو بانک
Analyzing net buyer seller activity in Oruka Therapeutics Inc.2025 Technical Overview & Stock Timing and Entry Methods - newser.com
1.43%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):